Seeking Capital or Licensing Deal? Here’s Why Digital RESI March is Important

17 Mar

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series; Caitlin Dolegowski, Marketing Specialist, LSN

Finding the right capital or channel partner is a numbers game, which means that you need to get in front of potential partners regularly. This is why the Redefining Early Stage Investments (RESI) conference takes place five times each year. You never know when a connection will surface that leads to a partnership, so you must be in the game to make it happen.

RESI is different from other partnering conferences in that it does real-time dynamic matching. The team at Life Science Nation (LSN) pre-loads investor profiles from mandates collected and stored in the LSN Investor Database. That is a big deal because (at most partnering events) investors typically have very light or even empty profiles. Because LSN has all the investors and licensing partners’ updated profiles in our database, this makes a huge difference in the quality of RESI meetings.

LSN can match based on fit, which in turn means great meetings can happen as both parties are looking for each other. Instead of booking a meeting and realizing there is no fit (which is common at other partnering conferences), RESI is unique because:

  1. There is the option to filter partners by capital investment and licensing mandates and match on stage of development and product.
  2. Most investor and licensing partner profiles are uploaded from our curated partnering database, so the user does not need to update their profile, unless they choose to, which has been a game-changer.
  3. Scientist-entrepreneurs and fundraising CEOs can opt to upgrade to a premier profile as part of RESI Premier Partnering to access deeper detailed investor mandates, which also include valuable contact information.

Another facet of Digital RESI March is the variety of panels focused on educating the entrepreneur on key components to partnering in the life science and health care early-stage arena. Hear straight from relevant investors and industry experts. These panels are created with the same intent and spirit of our partnering platform – To bring quality content with the early-stage life science entrepreneur in mind. Hear best practices, lessons learned, and valuable insight from our panelists. These panels are available to attendees live or their recordings are available on the meeting platform. Check out the panelists presenting at Digital RESI March below.

Tuesday, March 22, 11 AM EDT

Early-Stage Therapeutics

Bringing the Newest Therapies to the Clinic

Yaniv Sneor
Mid Atlantic Bio Angels
Cynthia Cai, PhD, MBA
Venture Partner
Viva BioInnovator
Catello Somma, MBA
;TVM Capital Life Science
Scott Weiner
Partner, Amzak Health
Sa’ar Yaniv
Director, Business Development, Fortress Biotech

Tuesday, March 22, 2 PM EDT

Digital Health & Wellness

Silver-Tech Focusing on Preventative Care

Brenda Hogan, MBA
Senior Investment Manager
Ontario Capital Growth Corporation (OCGC)
Moshe Bellows, JD
General Partner
Maccabee Ventures
Seemant Jauhari
Managing Partner

Tuesday, March 22, 3 PM EDT

Seed Funds

Investing in the Earliest Stage Companies

Andy Merken
Partner & Co-Chair, Life Sciences
Burns & Levinson
Dipty Desai, PhD
Co-Chair, TiE Global Health
TiE Angels
Matt Martin, PhD, MBA
Venture Partner
Pathway Bioventures
Gita Reinitz
Principal (NFX Bio)

Tuesday, March 22, 4 PM EDT

Tales from the Road: AI Innovators on their Fundraising Journey

Chelsea Sumner, PharmD
NALA Healthcare AI Startups Lead
Davide Vigano
Co-Founder & CEO
Ramji Srinivasan
Co-Founder & CEO 
Himanshu Misra, PhD
Enliten AI
Leila Pirhaji, PhD
Founder & CEO

Wednesday, March 23, 10AM EDT

Mental & Behavioral Health Panel

Investing in Technologies that Help Manage Well-Being

Lana Ghanem, MBA
Managing Director
Hikma Ventures
Raj Pallapothu
Managing Director
Bio 9 Ventures
Mayank Taneja, MBA
Director, Venture Investments
OSF Healthcare Ventures
Charlie Hartwell
Operating Partner
Bridge Builders Collaborative

Wednesday, March 23, 11 AM EDT

Age-Tech Devices

Seniors Embrace Innovative Medtech for Better Quality of Life

Lise Pape
Future Care Capital
Rick Robinson
Vice President, Startup Engagement
AARP Innovation Labs
Clarence Tan, PhD, MBA

Wednesday, March 23, 2 PM EDT

Medtech Strategics

Large Corporations Seeking External Innovation in MedTech

David Uffer
Senior Partner
Alira Health Ventures
Lana Caron, MBA
Innovation Lead
Philips Health Technology Ventures
Juan Cueva, PhD, MBA
Director, New Ventures & Early Innovation Partnering
Johnson & Johnson Innovation
Tali Hirsch
Director, Venture Investments
Fresenius Medical Care Ventures

Wednesday, March 23, 3 PM EDT

AI Drug Discovery and Development

How AI is Accelerating Therapeutic Advancement

Rafael Rosengarten, PhD
Co-Founder, Board Director & Executive Committee Member
The Alliance for Artificial Intelligence in Healthcare
Galym Imanbayev, MD, MBA
Lightspeed Venture Partners 
Linda Li
Managing Director
Vickers Venture Partners 
Thea Pham, PhD
Associate, Investments
OCV Partners 

Wednesday, March 23, 4 PM EDT

Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey

Greg Mannix
VP of International Business Development
Life Science Nation
Russell McAllister, MBA
Bold Therapeutics
Brian Hess, MBA
Alan Lucas
Co-Founder, CEO & Director
Navigation Sciences

Thursday, March 24, 11 AM EDT

Precision Medicine

Improving Outcomes through a Patient-Tailored Approach

David Crean
President & CEO
Coast BioVentures
Niall Kerrigan
Program Manager
Plug and Play Ventures
Eric de la Fortelle
Managing Partner
Cathay Capital

Thursday, March 24, 1 PM EDT

Cell & Gene Therapy

The Next Generation of Therapeutic Technologies

Nishta Rao
Managing Director – Life Science
First Republic Bank
Cynthia Lavoie
President & Chief Investment Officer
Centre for Commercialization of Regenerative Medicine
Scott Galasinski
Global Head, Business Development, Licensing & Strategy, Biopharmaceuticals R&D
Megan Krench
Director, Investments
Sanofi Ventures
Yury Kukushkin
Investment Director
Alicia Yin, PhD
Vice President
6 Dimensions Capital

Thursday, March 24, 2 PM EDT

Defining AI Investment

AI-Exclusive Investors Share Their Perspectives

Amit Garg, MBA
Co-Founder & Managing Partner
Tau Ventures
Navid Alipour, JD, MBA
Managing Partner
Analytics Ventures 
Isabel Fox
General Partner
Outsized Ventures
Gayathri Radhakrishnan, MBA
Senior Director, Venture Capital – AI Fund
Micron Technology 

Thursday, March 24, 4 PM EDT

Tales from the Road: Age-Tech Innovators on their Fundraising Journey

Jackie Marshall-Cyrus
Jackie Marshall-Cyrus & Associates Ltd
Char Hu, PhD
Co-Founder & CEO
The Helper Bees
Meredith Oppenheim
Founder & CEO
Vitality Society
Kyle Rand
Co-Founder & CEO


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: